Genmab and BliNK Biomedical Enter into Commercial License Agreement

    NEXT STORY
    World Biosensors Market Expected to Reach $34.3 Billion by 2025 — Biosensors in Asia-Pacific is Gaining Major Traction
    PREV STORY
    C-RAD and Elekta sign agreement to distribute C-RAD’s cutting-edge SIGRT solutions in America
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Ascendis Pharma Expands TransCon™ PTH Phase 2 PaTH Forward Clinical Trial to Expedite Enrollment of Subjects Previously Treated with NATPARA® in the United States

    author_avatar
    NASDAQ Market News

    Pivotal Phase 3 Data from CONVERT Study of ALIS in Patients with Treatment-Refractory NTM Lung Disease Caused by MAC Published in American Journal of Respiratory and Critical Care Medicine

    --As previously reported, study met primary endpoint of culture conversion (p<0.0001)-- --ALIS under FDA ...

    author_avatar
    NASDAQ Market News

    Evogene Reports Third Quarter 2018 Financial Results

    REHOVOT, Israel, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Conference call and webcast, today at ...

    author_avatar
    NASDAQ Market News